Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
Next Article Previous Article
- Wyden Launches Investigation Into Private Placement Life Insurance Schemes
- Wyden Statement on Republican IRS Conspiracy Theories
- Wyden Unveils Taxing Big Oil Profiteers Act
- Wyden Statement on New Rhodium Group Report Showing Benefits of Clean Energy Tax Package
- Wyden Stock Buyback Legislation Passes Senate